BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 30834543)

  • 1. Inflammatory endotypes in COPD.
    Barnes PJ
    Allergy; 2019 Jul; 74(7):1249-1256. PubMed ID: 30834543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
    [No Abstract]   [Full Text] [Related]  

  • 4. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
    Barrecheguren M; Esquinas C; Miravitlles M
    Curr Opin Pulm Med; 2015 Jan; 21(1):74-9. PubMed ID: 25405671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
    Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils in COPD-Current Concepts and Clinical Implications.
    Mycroft K; Krenke R; Górska K
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endo-phenotyping of COPD patients.
    Barnes PJ
    Expert Rev Respir Med; 2021 Jan; 15(1):27-37. PubMed ID: 32730716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eosinophilic inflammation in chronic obstructive pulmonary disease].
    Avdeev SN; Trushenko NV; Merzhoeva ZM; Ivanova MS; Kusraeva EV
    Ter Arkh; 2019 Oct; 91(10):144-152. PubMed ID: 32598645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait.
    David B; Bafadhel M; Koenderman L; De Soyza A
    Thorax; 2021 Feb; 76(2):188-195. PubMed ID: 33122447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway inflammation in COPD: progress to precision medicine.
    Brightling C; Greening N
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31073084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease.
    Yi X; Li Y; Liu H; Liu X; Yang J; Gao J; Yang Y; Liang Z; Wang F; Chen D; Wang L; Shi W; Lam DCL; Stampfli MR; Jones PW; Chen R; Wang Z
    Microbiol Spectr; 2022 Apr; 10(2):e0259321. PubMed ID: 35311590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic Therapy in Chronic Obstructive Pulmonary Disease.
    Tripple JW; McCracken JL; Calhoun WJ
    Immunol Allergy Clin North Am; 2017 May; 37(2):345-355. PubMed ID: 28366481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.
    Tashkin DP; Wechsler ME
    Int J Chron Obstruct Pulmon Dis; 2018; 13():335-349. PubMed ID: 29403271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood eosinophils in COPD: friend or foe?
    Papaporfyriou A; Bakakos P; Hillas G; Papaioannou AI; Loukides S
    Expert Rev Respir Med; 2022 Jan; 16(1):35-41. PubMed ID: 34821191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers.
    Garudadri S; Woodruff PG
    Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S234-S238. PubMed ID: 30758998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of inflammatory cell function by corticosteroids.
    Belvisi MG
    Proc Am Thorac Soc; 2004; 1(3):207-14. PubMed ID: 16113436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
    Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
    Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.